← Evidence map

ArticleCell reports. Medicine2026

Debio 1562M CD37-targeting ADC is highly active and well tolerated in preclinical models of AML and MDS.

Léo Marx et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42013843